Back
Intra-Cellular Therapies Stock Predictions
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
45
ITCI
Intra-Cellular Therapies
Last Price:
73.04
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.Intra-Cellular Therapies Stock Forecast
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 28.2% based on the past 10 years of stock performance.
- Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $74.01. The Score for ITCI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 28.2% based on the past 10 years of stock performance.
Intra-Cellular Therapies Stock Rating
Sell
45
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies overpriced?
- Intra-Cellular Therapies has risen higher in 8 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Intra-Cellular Therapies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
84.89
52-Week Low:
45.50
Prediction Charts
Market Cap:
7.16B
Price in USD:
74.01
Volume:
719.38K
Beta:
1.11
Technical Analysis
SMA50:
69.38
SMA100:
68.16
SMA200:
62.12
52-Wk Change:
18.4%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company. -
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 74.01 USD today. -
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-4 | 68.49 | 67.21 | 69.33 | 66.61 |
| Apr-5 | 67.29 | 68.45 | 69.50 | 67.02 |
| Apr-8 | 68.74 | 67.72 | 68.91 | 67.33 |
| Apr-9 | 68.07 | 68.63 | 69.02 | 67.90 |
| Apr-10 | 67.12 | 67.25 | 68.12 | 66.53 |
| Apr-11 | 67.89 | 67.97 | 68.68 | 66.53 |
| Apr-12 | 68.04 | 65.88 | 68.67 | 64.84 |
| Apr-15 | 65.71 | 64.77 | 66.05 | 64.16 |
| Apr-16 | 75.29 | 79.86 | 84.89 | 75.00 |
| Apr-17 | 79.00 | 76.69 | 83.25 | 76.50 |
| Apr-18 | 74.40 | 72.04 | 75.08 | 71.21 |
| Apr-19 | 72.31 | 72.37 | 74.56 | 70.93 |
| Apr-22 | 73.68 | 74.58 | 75.14 | 72.02 |
| Apr-23 | 75.06 | 74.01 | 76.89 | 73.69 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.96 per share, and an increase next year of $1.47 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.